Translational projects at Empa and PSI get extra funding

Following a selection process by an international review panel, the Executive Committee of the ETH Board's Strategic Focus Area Personalized Health and Related Technologies (PHRT) has chosen to fund three projects from the Paul Scherrer Institute (PSI) and Empa with an overall budget of CHF 1 million. Through its Strategic Focus Area Personalized Health and Related Technologies (PHRT), in collaboration with Swiss hospitals, the ETH Domain has been promoting the integration of ETH technologies into clinical practice for the benefit of patients since 2017. Expressing his enthusiasm for the newly funded projects, Bernd Wollscheid, Chairman of the review panel, stated: "By supporting these three projects spearheaded by Empa and PSI, PHRT enables innovative technologies developed within ETH Domain institutions to be evaluated with clinical partners on human samples. Successful translation of such projects today and further testing in clinical trials are the basis for new diagnostic and therapeutic strategies benefiting patients tomorrow." These groundbreaking studies, funded by PHRT, exemplify the ETH Domain's commitment to, together with its clinical partners, drive the future of healthcare. By leveraging novel technologies and algorithms developed by the ETH Domain's institutions, these projects aim to enhance clinical decision-making and therapeutics, benefiting patients in Switzerland and worldwide. The project proposed by Inge Herrmann from Empa in collaboration with the Cantonal Hospital of St. Gallen and the Cleveland Clinic (USA) aims at developing a monitoring system to analyze the surgical drain fluid after digestive surgery.